Investors

Investors

American Society of Clinical Oncology (ASCO) Annual Meeting

1 June 2015

AstraZeneca will be hosting a briefing for analysts and investors during the American Society of Clinical Oncology (ASCO) Annual Meeting to be held in Chicago on Monday 1 June 2015, from 8:30pm –10:00pm CDT (2 June 2:30am -4:00am BST – UK). The aim of this event is to update on progress with AstraZeneca’s immuno-oncology pipeline and combination treatments.

You will be able to listen to the event using the following dial in details:

UK freephone: 0800 694 0257
US freephone: 866 966 9439
Sweden freephone: 0200 890171
International: +44 (0) 1452 555566

Conference code: 42762226


Latest downloads

AstraZeneca Mölndal

22 May 2015

First quarter results 2015

24 April 2015

Investor science conference call ACC 2015

16 March 2015

AstraZeneca refines its financial reporting in line with evolving business model

6 March 2015

Investor Relations presentation - March 2015

5 March 2015

Fourth quarter and full year results 2014

5 February 2015


Share price

London
44.74 GBP
New York
69.45 USD
Stockholm
582.50 SEK

At 22-5-2015 21:33 GMT

Detailed share price


Stock symbol - AZN

On LSE, NYE and OMX